# Aadi Bioscience (stock symbol: AADI) Logo in transparent PNG format

## Aadi Bioscience Logo large

### Aadi Bioscience Logo large Download PNG (97.48 KB)

![Aadi Bioscience Logo large Download PNG (97.48 KB)](/img/orig/AADI_BIG-521f5f34.png)

## Aadi Bioscience Logo icon format

### Aadi Bioscience Logo icon format Download PNG (11.47 KB)

![Aadi Bioscience Logo icon format Download PNG (11.47 KB)](/img/orig/AADI-5a12840b.png)

## Aadi Bioscience Logo large for dark backgrounds

### Aadi Bioscience Logo large for dark backgrounds Download PNG (96.47 KB)

![Aadi Bioscience Logo large for dark backgrounds Download PNG (96.47 KB)](/img/orig/AADI_BIG.D-31149c2e.png)

## Aadi Bioscience Logo icon format for dark backgrounds

### Aadi Bioscience Logo icon format for dark backgrounds Download PNG (11.21 KB)

![Aadi Bioscience Logo icon format for dark backgrounds Download PNG (11.21 KB)](/img/orig/AADI.D-94ef84d2.png)

## About Aadi Bioscience

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

1. Website domain: aadibio.com
2. Employees: 67
3. Marketcap: $0.18 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
